Tencent and Medopad Team Up to Diagnose Parkinson Disease through AI

Must Read

Huawei unveils Mate 30 Pro with 7,680fps slow-mo and Waterfall display

Despite the tensions between US-China regarding trade wars, Huawei officially announces the all-new Huawei Mate 30 series without Google...

How to solve iOS update problems

A newer and enhanced version of anything encourages people to try. This is because it brings convenience...

The number one reason vaping devices explode

Over the past several years, we’ve watched so-called “cigalikes” and vapes steal the show from Big Tobacco...
Avatar for Jazib Zaman
Areen Zahra
IT professional and a passionate writer who enjoys putting my love of technology into words for a general audience.

It’s always a treat when technology and medicine meet. It is even more interesting when you see two powers join hands to serve a cause especially in a field where they are already competing.

The Chinese tech giant Tencent has teamed up with a renowned medical firm of London, Medopad to use artificial intelligence for the diagnosis of Parkinson Disease.

Ever wondered about the trauma and pain that patients with Parkinson’s disease go through? All those trips to the hospital with shaky hands and imbalanced steps?

The Chinese and UK based firms have come together to facilitate the patients with Parkinson’s disease to make things easier for them.
Medopad is a sprouting UK based firm that has been making software to treat Patients. Medopad has developed a smartphone technology that would monitor Parkinson’s patients in less than 4 minutes without having the need to visit the hospital.

Tencent, as compared to Medopad, is a Chinese tech giant that has made some significant investment in the AI world. Tencent is contributing to the cause by providing AI solutions that can detect the deterioration of Parkinson’s disease in patients without using any physical sensors or devices.

This goal is achieved through a smart camera that monitors and analyzes patients’ movement to figure out the severity of the disease. The research team supervising this project has trained the AI with existing videos and records from original patients. The system is learning different behaviors and severity of these behaviors. Artificial intelligence is expected to perform results based on these learned behaviors.

The collaboration aims at reducing the assessment time for patients as well as making the process a lot more comfortable and torture free. In an interview with BBC, Wei Fan made a statement that reads:

“We are looking forward to clinical trials in both China and US and other countries. We will strictly follow local regulations and when we have the results they will benefit not just one country but globally”.

The most critical task for this joint venture is to refrain from all kinds of political involvements and influences to proceed.

We wish best of luck to both entities for their continued success.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest News

Huawei unveils Mate 30 Pro with 7,680fps slow-mo and Waterfall display

Despite the tensions between US-China regarding trade wars, Huawei officially announces the all-new Huawei Mate 30 series without Google...

How to solve iOS update problems

A newer and enhanced version of anything encourages people to try. This is because it brings convenience in life when something promises...

The number one reason vaping devices explode

Over the past several years, we’ve watched so-called “cigalikes” and vapes steal the show from Big Tobacco and the cigarette industry, as...

How to sync Google Drive with OneDrive

Nowadays, cloud storage is becoming more and more popular as a means of storing and backing up data. Among multiple cloud drives,...

Apple TV+ is just $4.99 per month, free first year with new Apple products

The Apple Event 2019 took place on September 10th, 2019, in Cupertino, California. The event highlighted various upcoming releases by Apple, and one...

More Articles Like This